Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.020
-0.030 (-0.98%)
At close: Aug 14, 2026, 4:00 PM EDT
3.040
+0.020 (0.66%)
After-hours: Aug 14, 2026, 7:42 PM EDT
Niagen Bioscience Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Niagen Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $12.08. The average 1-year stock price forecast is 300.00% higher than the current stock price, while the lowest is $8.50 (+181.46%) and the highest is $22 (+628.48%).
Price Target: $12.08 (+300.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $10 | Buy | Reiterates | $10 | +231.13% | Aug 12, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +231.13% | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +264.24% | Aug 5, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +264.24% | Jul 21, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Initiates $9 | Buy | Initiates | $9 | +198.01% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
133.11M
from 129.42M
Increased by 2.85%
Revenue Next Year
155.31M
from 133.11M
Increased by 16.67%
EPS This Year
0.09
from 0.17
Decreased by -46.24%
EPS Next Year
0.10
from 0.09
Increased by 11.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.